Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080681 | SCV000112583 | uncertain significance | not provided | 2017-11-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082735 | SCV000625931 | benign | Duchenne muscular dystrophy | 2024-11-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354278 | SCV002657705 | likely benign | Cardiovascular phenotype | 2019-11-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323390 | SCV004029846 | benign | not specified | 2023-07-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001831863 | SCV002090493 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-06-27 | no assertion criteria provided | clinical testing |